(FM) Oncología
Departamento académico
Beckman Research Institute
City of Hope, Estados UnidosPublications in collaboration with researchers from Beckman Research Institute (1)
2023
-
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
Nature Communications, Vol. 14, Núm. 1